Hu J - Search Results

1

Promoter methylation induced epigenetic silencing of DAZAP2, a downstream effector of p38/MAPK pathway, in multiple myeloma cells.

Li J, Hu WX, Luo SQ, Xiong DH, Sun S, Wang YP, Bu XF, Liu J, Hu J. Li J, et al. Among authors: hu j, hu wx. Cell Signal. 2019 Aug;60:136-145. doi: 10.1016/j.cellsig.2019.04.012. Epub 2019 Apr 26. Cell Signal. 2019. PMID: 31034872

2

The effects of promoter methylation on downregulation of DAZAP2 in multiple myeloma cell lines.

Luo SQ, Hu JP, Qu Q, Li J, Ren W, Zhang JM, Zhong Y, Hu WX. Luo SQ, et al. Among authors: hu jp, hu wx. PLoS One. 2012;7(7):e40475. doi: 10.1371/journal.pone.0040475. Epub 2012 Jul 9. PLoS One. 2012. PMID: 22792345 Free PMC article.

3

Global transcriptome analyses of human and murine terminal erythroid differentiation.

An X, Schulz VP, Li J, Wu K, Liu J, Xue F, Hu J, Mohandas N, Gallagher PG. An X, et al. Among authors: hu j. Blood. 2014 May 29;123(22):3466-77. doi: 10.1182/blood-2014-01-548305. Epub 2014 Mar 17. Blood. 2014. PMID: 24637361 Free PMC article.

4

Targeting signaling pathways in multiple myeloma: Pathogenesis and implication for treatments.

Hu J, Hu WX. Hu J, et al. Among authors: hu wx. Cancer Lett. 2018 Feb 1;414:214-221. doi: 10.1016/j.canlet.2017.11.020. Epub 2017 Nov 22. Cancer Lett. 2018. PMID: 29174802 Review.

5

Knockdown of spliceosome U2AF1 significantly inhibits the development of human erythroid cells.

Zhang J, Zhao H, Wu K, Peng Y, Han X, Zhang H, Liang L, Chen H, Hu J, Qu X, Zhang S, Chen L, Liu J. Zhang J, et al. Among authors: hu j. J Cell Mol Med. 2019 Aug;23(8):5076-5086. doi: 10.1111/jcmm.14370. Epub 2019 May 29. J Cell Mol Med. 2019. PMID: 31144421 Free PMC article.

6

C1orf35 contributes to tumorigenesis by activating c-MYC transcription in multiple myeloma.

Luo SQ, Xiong DH, Li J, Li G, Wang Y, Zhang JM, Bu XF, Hu WX, Hu J. Luo SQ, et al. Among authors: hu j, hu wx. Oncogene. 2020 Apr;39(16):3354-3366. doi: 10.1038/s41388-020-1222-7. Epub 2020 Feb 27. Oncogene. 2020. PMID: 32103167

7

Transcriptional profiling of Microtus fortis responses to S. japonicum: New sight into Mf-Hsp90α resistance mechanism.

Xiong D, Luo S, Wu K, Yu Y, Sun J, Wang Y, Hu J, Hu W. Xiong D, et al. Among authors: hu w, hu j. Parasite Immunol. 2021 Aug;43(8):e12842. doi: 10.1111/pim.12842. Epub 2021 Jun 9. Parasite Immunol. 2021. PMID: 33959966 Free PMC article.

8

Chromosome 1 instability in multiple myeloma: Aberrant gene expression, pathogenesis, and potential therapeutic target.

Luo S, Su T, Zhou X, Hu WX, Hu J. Luo S, et al. Among authors: hu j, hu wx. FASEB J. 2022 Jun;36(6):e22341. doi: 10.1096/fj.202200354. FASEB J. 2022. PMID: 35579877 Review.

9

Targeting myeloma metabolism: How abnormal metabolism contributes to multiple myeloma progression and resistance to proteasome inhibitors.

Zhou X, He R, Hu WX, Luo S, Hu J. Zhou X, et al. Among authors: hu j, hu wx. Neoplasia. 2024 Apr;50:100974. doi: 10.1016/j.neo.2024.100974. Epub 2024 Feb 16. Neoplasia. 2024. PMID: 38364355 Free PMC article. Review.

10

Isolation and functional characterization of human erythroblasts at distinct stages: implications for understanding of normal and disordered erythropoiesis in vivo.

Hu J, Liu J, Xue F, Halverson G, Reid M, Guo A, Chen L, Raza A, Galili N, Jaffray J, Lane J, Chasis JA, Taylor N, Mohandas N, An X. Hu J, et al. Blood. 2013 Apr 18;121(16):3246-53. doi: 10.1182/blood-2013-01-476390. Epub 2013 Feb 19. Blood. 2013. PMID: 23422750 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37,102 results

Search Page

Filters